Operating Segments

3 Months Ended

Mar. 31, 2020

Segment Reporting [Abstract]

Operating Segments

Note 10. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended March 31,
	2020			2019
Revenues
Public Health Solutions	$	908,807		$	680,353
Specialized BioTherapeutics		15,745			464,435
Total	$	924,552		$	1,144,788
Loss from Operations
Public Health Solutions	$	(158,502	)	$	(9,011	)
Specialized BioTherapeutics		(7,357,853	)		(1,335,557	)
Corporate		(957,437	)		(955,495	)
Total	$	(8,473,792	)	$	(2,300,063	)
Amortization and Depreciation Expense
Public Health Solutions	$	7,303		$	4,402
Specialized BioTherapeutics		3,070			4,677
Corporate		7,273			2,841
Total	$	17,646		$	11,920
Other Income, Net
Specialized BioTherapeutics	$	33,618		$	5,007
Corporate		21,947			44,753
Total	$	55,565		$	49,760
Share-Based Compensation
Public Health Solutions	$	9,465		$	5,196
Specialized BioTherapeutics		25,289			20,908
Corporate		28,937			53,469
Total	$	63,691		$	79,573

	As of		As of
	March 31,		December 31,
	2020		2019
Identifiable Assets
Public Health Solutions	$	813,121	$	1,018,673
Specialized BioTherapeutics		64,351		41,705
Corporate	$	8,970,202	$	6,714,982
Total	$	9,847,674	$	7,775,360